Your browser doesn't support javascript.
loading
Socio-economic association of alcohol use disorder and cardiovascular and alcohol-associated liver disease from 2010 to 2019.
Danpanichkul, Pojsakorn; Chen, Vincent L; Chaiyakunapruk, Nathorn; Auttapracha, Thanida; Kongarin, Siwanart; Ng, Cheng Han; Duangsonk, Kwanjit; Muthiah, Mark D; Sukphutanan, Banthoon; Sim, Benedix; Huang, Daniel Q; Seko, Yuya; Lee, Brian P; Takahashi, Hirokazu; Noureddin, Mazen; Lazarus, Jeffrey V; Díaz, Luis Antonio; Arab, Juan Pablo; Mellinger, Jessica Leigh; Liangpunsakul, Suthat; Wijarnpreecha, Karn.
Afiliação
  • Danpanichkul P; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
  • Chen VL; Immunology Unit, Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Chaiyakunapruk N; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.
  • Auttapracha T; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah, USA.
  • Kongarin S; IDEAS Center, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah, USA.
  • Ng CH; Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Duangsonk K; Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Muthiah MD; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Sukphutanan B; Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Sim B; Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore.
  • Huang DQ; Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Seko Y; Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore.
  • Lee BP; Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore.
  • Takahashi H; MASLD Research Center, Division of Gastroenterology, University of California at San Diego, San Diego, California, USA.
  • Noureddin M; Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kyoto, Japan.
  • Lazarus JV; Division of Gastroenterology and Liver Diseases, University of Southern California, Los Angeles, California, USA.
  • Díaz LA; Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga, Japan.
  • Arab JP; Houston Research Institute and Houston Methodist Hospital, Houston, Texas, USA.
  • Mellinger JL; CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, New York, USA.
  • Liangpunsakul S; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
  • Wijarnpreecha K; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
Aliment Pharmacol Ther ; 60(3): 340-349, 2024 08.
Article em En | MEDLINE | ID: mdl-38808961
ABSTRACT
BACKGROUNDS AND

AIMS:

Alcohol use leads to disabilities and deaths worldwide. It not only harms the liver but also causes alcohol use disorder (AUD) and heart disease. Additionally, alcohol consumption contributes to health disparities among different socio-economic groups.

METHODS:

We estimated global and regional trends in the burden of AUD, liver disease, and cardiovascular disease from alcohol using the methodology of the Global Burden of Disease study.

RESULTS:

In 2019, the highest disability-adjusted life years rate per 100,000 population was due to AUD (207.31 [95% Uncertainty interval (UI) 163.71-261.66]), followed by alcohol-associated liver disease (ALD) (133.31 [95% UI 112.68-156.17]). The prevalence rate decreased for AUD (APC [annual percentage change] -0.38%) and alcohol-induced cardiomyopathy (APC -1.85%) but increased for ALD (APC 0.44%) and liver cancer (APC 0.53%). Although the mortality rate for liver cancer from alcohol increased (APC 0.30%), mortality rates from other diseases decreased. Between 2010 and 2019, the burden of alcohol-associated complications increased in countries with low and low-middle sociodemographic index (SDI), contributing more significantly to the global burden.

CONCLUSION:

The global burden of AUD, liver, and cardiovascular disease has been high and increasing over the past decade, particularly for liver complications. Lower SDI countries are contributing more to this global burden. There is a pressing need for effective strategies to address this escalating burden.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores Socioeconômicos / Doenças Cardiovasculares / Alcoolismo / Carga Global da Doença / Hepatopatias Alcoólicas Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores Socioeconômicos / Doenças Cardiovasculares / Alcoolismo / Carga Global da Doença / Hepatopatias Alcoólicas Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article